Abstract:Neuroimaging plays a pivotal role in the clinical practice of brain tumors aiding in the diagnosis, genotype prediction, preoperative planning, and prognostication. The brain tumors most commonly seen in adults are extra-axial lesions like meningioma, intra-axial lesions like gliomas and lesions of the pituitary gland. Clinical features may be localizing like partial seizures, weakness, and sensory disturbances or nonspecific like a headache. On clinical suspicion of a brain tumor, the primary investigative workup should focus on imaging. Other investigations like fundoscopy and electroencephalography may be performed depending on the clinical presentation. Obtaining a tissue sample after identifying a brain tumor on imaging is crucial for confirming the diagnosis and planning further treatment. Tissue sample may be obtained by techniques such as stereotactic biopsy or upfront surgery. The magnetic resonance (MR) imaging protocol needs to be standardized and includes conventional sequences like T1-weighted (T1W) imaging with and without contrast, T2w imaging, fluid-attenuated axial inversion recovery, diffusion-weighted imaging (DWI), susceptibility-weighted imaging, and advanced imaging sequences like MR perfusion and MR spectroscopy. Various tumor characteristics in each of these sequences can help us narrow down the differential diagnosis and also predict the grade of the tumor. Multidisciplinary co-ordination is needed for proper management and care of brain tumor patients. Treatment protocols need to be adapted and individualized for each patient depending on the age, general condition of the patient, histopathological characteristics, and genotype of the tumor. Treatment options include surgery, radiotherapy, and chemotherapy. Imaging also plays a vital role in post-treatment follow-up. Sequences like DWI, MR perfusion, and MR spectroscopy are useful to distinguish post-treatment effects like radiation necrosis and pseudoprogression from true recurrence. Radiological reporting of brain tumor images should follow a structured format to include all the elements that could have an impact on the treatment decisions in patients.

Imaging Recommendations for Diagnosis, Staging, and Management of Hematological Malignancies

Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer

Guidelines for the use of imaging in the management of patients with myeloma

Imaging Recommendations for Diagnosis, Staging, and Management of Lung Cancer

Hematologic cancer diagnosis and classification using machine and deep learning: State-of-the-art techniques and emerging research directives

Bone tumors: state-of-the-art imaging

Imaging Recommendations for the Diagnosis, Staging, and Management of Adult Brain Tumors

Haemato-Radiology: The role of the Radiologist at MDT

Imaging Diagnosis of Pulmonary Lymphomas

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

Imaging Modalities for Head and Neck Cancer: Present and Future

Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation

Recent Imaging Updates and Advances in Gynecologic Malignancies

Imaging evaluation of thymic tumors

Anatomic Approach to Common and Uncommon Manifestations of Thoracic Leukemias with Radiologic-Pathologic Correlation

Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer

Magnetic Resonance Imaging of Gynecological Malignancies: Role in Personalized Management

Imaging of Lung Cancer Staging

Comprehensive review of post-treatment imaging in head and neck cancers: from expected to unexpected and beyond

Imaging in Lung Cancer Staging